- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in BioNTech
Pfizer COVID-19 vaccine will be made available across UK from next week: PM
Pfizer COVID-19 vaccine will be made available across UK from next week: PM
Read MoreUK authorises Pfizer, BioNTech COVID-19 vaccines, delivery from next week
UK authorises Pfizer, BioNTech COVID-19 vaccines, delivery from next week
Read MorePfizer, BioNTech submit application to register COVID-19 vaccine in EU
Pfizer, BioNTech submit application to register COVID-19 vaccine in EU
Read MorePfizer-BioNTech Apply For EU Emergency Authorization For COVID-19 Vaccine
The application to the European Medicines Agency (EMA) comes after the companies applied for U.S. approval on Nov. 20, taking them a step closer to launching their vaccine.
Read MoreModerna To Charge $25-$37 For COVID-19 Vaccine, CEO Tells Paper
Moderna has said its experimental vaccine is 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.
Read MorePfizer, BioNTech to submit to FDA for emergency use authorisation for their COVID-19 vaccine candidate
Pfizer, BioNTech to submit to FDA for emergency use authorisation for their COVID-19 vaccine candidate
Read MoreEU Could Pay Over $10 Billion For Pfizer And Curevac Vaccines
The EU has separately agreed to pay 10 euros ($11.84) per dose for an initial supply of 225 million doses of the vaccine candidate from CureVac, a discount from the 12 euros the company set as the price for the shot, the official said.
Read MorePfizer, BioNTech offer Brazil COVID-19 vaccination plan for 2021
Pfizer, BioNTech offer Brazil COVID-19 vaccination plan for 2021
Read MorePfizer, BioNTech Conclude Phase 3 Study Of COVID-19 Vaccine Candidate, Say It's 95% Effective
The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent
Read MorePfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent effective
Pfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent effective
Read MoreSpain Authorises Phase III Trial Of Johnson & Johnson COVID-19 Vaccine
The Phase III trial of the two-dose vaccination will be carried out in nine hospitals throughout Spain on volunteers both with and without previous health conditions
Read MoreS&P 500 Hits All-Time Closing High After Earnings, Oil Drops On Pandemic Worry
The Dow Jones Industrial Average rose 399.64 points, or 1.37%, to 29,479.81, the S&P 500 gained 48.14 points, or 1.36%, to 3,585.15 and the Nasdaq Composite added 119.70 points, or 1.02%, to 11,829.29.
Read MoreBioNTech says no infomation on vaccination start in Germany
BioNTech says no infomation on vaccination start in Germany
Read MoreNasdaq Retreats As Technology Stocks Lose Favor
The Dow Jones Industrial Average rose 262.95 points, or 0.9%, to 29,420.92, the S&P 500 lost 4.97 points, or 0.14%, to 3,545.53 and the Nasdaq Composite dropped 159.93 points to 11,553.86.
Read MoreOil Gains Nearly 3% On Vaccine Hopes, Even As Nations Reimpose Lockdowns
Brent crude futures settled up $1.21, or 2.9%, at $43.61 per barrel. U.S. West Texas Intermediate (WTI) crude futures gained $1.07, or 2.7%, to $41.36.
Read More